- Home
- FET vs ACIU Comparison
FET vs ACIU Comparison
Compare FET & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FET
- ACIU
- Stock Information
- Founded
- FET 2005
- ACIU 2003
- Country
- FET United States
- ACIU Switzerland
- Employees
- FET N/A
- ACIU N/A
- Industry
- FET Metal Fabrications
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- FET Industrials
- ACIU Health Care
- Exchange
- FET Nasdaq
- ACIU Nasdaq
- Market Cap
- FET 187.2M
- ACIU 173.7M
- IPO Year
- FET 2012
- ACIU 2016
- Fundamental
- Price
- FET $14.74
- ACIU $1.71
- Analyst Decision
- FET
- ACIU Strong Buy
- Analyst Count
- FET 0
- ACIU 2
- Target Price
- FET N/A
- ACIU $10.00
- AVG Volume (30 Days)
- FET 51.0K
- ACIU 106.3K
- Earning Date
- FET 05-01-2025
- ACIU 04-30-2025
- Dividend Yield
- FET N/A
- ACIU N/A
- EPS Growth
- FET N/A
- ACIU N/A
- EPS
- FET N/A
- ACIU N/A
- Revenue
- FET $807,312,000.00
- ACIU $32,014,254.00
- Revenue This Year
- FET N/A
- ACIU N/A
- Revenue Next Year
- FET $1.72
- ACIU $577.48
- P/E Ratio
- FET N/A
- ACIU N/A
- Revenue Growth
- FET 7.31
- ACIU 91.20
- 52 Week Low
- FET $12.78
- ACIU $1.43
- 52 Week High
- FET $21.57
- ACIU $4.98
- Technical
- Relative Strength Index (RSI)
- FET 46.36
- ACIU 52.14
- Support Level
- FET $14.52
- ACIU $1.65
- Resistance Level
- FET $15.09
- ACIU $1.75
- Average True Range (ATR)
- FET 0.59
- ACIU 0.10
- MACD
- FET 0.04
- ACIU 0.01
- Stochastic Oscillator
- FET 22.44
- ACIU 68.97
About FET Forum Energy Technologies Inc.
Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.